Patient Pathfinder: Clinical Trials
Clinical Trials for Lung Cancer
Every life-saving or life-extending treatment that’s available today for cancer started its journey in a clinical trial. A clinical trial is a study that helps doctors better understand cancer, and discover safer and more effective ways to treat it.
Clinical trials also give patients a chance to try a treatment before it’s approved by the U.S. Food and Drug Administration.
There are 986 active Lung Cancer trials
First-in-human Study of DRP-104 (Sirpiglenastat) as Single Agent and in Combination With Atezolizumab in Patients With Advanced Solid Tumors.
Study Type: Interventional Phase 1
Image-Guided, Intensity-Modulated Photon or Proton Beam Radiation Therapy in Treating Patients With Stage II-IIIB Non-small Cell Lung Cancer
Study Type: Interventional Phase 1
Priming Immunotherapy in Advanced Disease With Radiation
Study Type: Interventional Phase 2
The Lung Screening, Tobacco and Health Project
Study Type: Interventional Phase 3
Nab-Paclitaxel With Gemcitabine for Relapsed Small Cell Cancer
Study Type: Interventional Phase 2
A Study of NM21-1480 in Adult Patients With Advanced Solid Tumors
Study Type: Interventional Phase 1
Olaparib in Patients With HRD Malignant Mesothelioma
Study Type: Interventional Phase 2
There are 986 active Lung Cancer trials
Filter Results
Phase
Study Type
Need more help finding a clinical trial that's the right fit?
Explore our Clinical Trial Finder.
Start NowNeed more help finding a clinical trial that's the right fit?
Explore our Clinical Trial Finder.
Start Now